Hemas Pharmaceuticals News and Activities

Hemas Pharmaceuticals is owned by Hemas. Hemas has a direct presence in 2 countries.

Hemas has 5 subsidiaries including Adlumin, Hemas Pharmaceuticals and Morison.

They are in:

• Industrial Conglomerates17%
• Pharmaceuticals17%
• Other67%

View the org chart displaying its 10 main executives

Most searched biographies at Hemas Pharmaceuticals

• Jude Fernando, Managing Director
• Chinthaka Perera, General Manager Sales
• Sriyantha Waas, General Manager, Business Transformation

Create your alert
to follow the executive moves at Hemas Pharmaceuticals.

Hemas has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Hemas Pharmaceuticals

• News & Insights | Leading pharmaceutical Company Sri Lanka - Page 2
• News & Insights | Leading pharmaceutical Company Sri Lanka

Social media about Hemas Pharmaceuticals

• Hemas Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Hemas Pharmaceuticals on LinkedIn, X (Twitter) & YouTube